5CX-18204-27661 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-29
Dose 1 — Pfizer-BioNTech
2021-04-19
Dose 2 — Pfizer-BioNTech
2021-04-20
Registered in v-safe
2021-04-20
Survey response — days 1–6 daily, dose 2
MedDRA: Pain in extremity — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Painful fingertips (especially when in contact with running water)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Survey response — days 1–6 daily, dose 2
MedDRA: Pruritus — Feeling: Good · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities

Free text: Itchiness but no rash

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-26
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-10
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-31
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-19
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-18
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-23
Dose 3 — Pfizer-BioNTech
2022-04-19
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-05-26
Survey response — 6 months, dose 3
MedDRA: COVID-19, Cough, Malaise — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Got sick with covid. Has lingering cough.

MedDRA releases: 2024-11 · check-in free text available
2022-05-26
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-27
Call successful
Participant prefers to complete VAERS report online
2022-11-23
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-29	Pfizer-BioNTech
2	2021-04-19	Pfizer-BioNTech
3	2021-11-23	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-05-26	Successful 2022-05-27	Participant prefers to complete VAERS report online

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-20

Systemic reaction (other): Painful fingertips (especially when in contact with running water)

2021-04-21

Systemic reaction (other): Itchiness but no rash

Release 11 — 6 months, dose 3

2022-05-26

Symptoms: Got sick with covid. Has lingering cough.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Malaise	·	·	✓
SRO	Pain in extremity	✓	✓	✓
SRO	Pruritus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release